In Vitro Bioavailability Study of an Antiviral Compound Enisamium Iodide
AbstractAn investigation into the biopharmaceutics classification and a study of the in vitro bioavailability (permeability and solubility) of the antiviral compound enisamium iodide (4-(benzylcarbamoyl)-1-methylpyridinium iodide) were carried out. The solubility of enisamium iodide was determined in four different buffers. Apparent intestinal permeability (Papp) of enisamium iodide was assessed using human colon carcinoma (Caco-2) cells at three concentrations. The solubility of enisamium iodide in four buffer solutions from pH 1.2 to 7.5 is about 60 mg/mL at 25 °C, and ranges from 130 to 150 mg/mL at 37 °C, depending on the pH. Based on these results, enisamium iodide can be classified as highly soluble. Enisamium iodide demonstrated low permeability in Caco-2 experiments in all tested concentrations of 10–100 μM with permeability coefficients between 0.2 × 10−6 cm s−1 and 0.3 × 10−6 cm s−1. These results indicate that enisamium iodide belongs to class III of the Biopharmaceutics Classification System (BCS) due to its high solubility and low permeability. The bioavailability of enisamium iodide needs to be confirmed in animal and human studies. View Full-Text
Share & Cite This Article
Haltner-Ukomadu, E.; Gureyeva, S.; Burmaka, O.; Goy, A.; Mueller, L.; Kostyuk, G.; Margitich, V. In Vitro Bioavailability Study of an Antiviral Compound Enisamium Iodide. Sci. Pharm. 2018, 86, 3.
Haltner-Ukomadu E, Gureyeva S, Burmaka O, Goy A, Mueller L, Kostyuk G, Margitich V. In Vitro Bioavailability Study of an Antiviral Compound Enisamium Iodide. Scientia Pharmaceutica. 2018; 86(1):3.Chicago/Turabian Style
Haltner-Ukomadu, Eleonore; Gureyeva, Svitlana; Burmaka, Oleksii; Goy, Andriy; Mueller, Lutz; Kostyuk, Grygorii; Margitich, Victor. 2018. "In Vitro Bioavailability Study of an Antiviral Compound Enisamium Iodide." Sci. Pharm. 86, no. 1: 3.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.